GIEQ - ETF AI Analysis
Top Page
Goldman Sachs Data Enhanced International Equity ETF (GIEQ)
Rating:66Neutral
Price Target:―
Positive Factors
Strong Leading Holding
The largest position, ASML Holding, has shown strong gains this year, providing a solid boost to the ETF’s overall results.
Broad International Diversification
The fund spreads its investments across many countries in Europe, Asia, and other regions, helping reduce the impact of problems in any single market.
Reasonable Expense Ratio
The ETF’s expense ratio is moderate for an actively managed international strategy, which helps investors keep more of their returns over time.
Negative Factors
Mixed Recent Performance
While the ETF is up so far this year, its recent one-month return has been weak, showing that short-term results can be bumpy.
Concentration in a Few Countries
A large share of the portfolio is invested in Japan, the UK, France, and Germany, which increases the fund’s sensitivity to economic or political issues in those markets.
Top Holdings Not All Strong
Some major positions like Nestlé and Unilever have been lagging this year, which can offset gains from stronger stocks in the portfolio.
GIEQ vs. SPDR S&P 500 ETF (SPY)
AUM42.83M
RegionGlobal Ex-U.S.
Expense Ratio0.30%
Beta0.77
IssuerGoldman Sachs
Inception DateMay 19, 2026
Dividend YieldN/A
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume1,133
30 Day Avg. Volume15,306
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
48.94Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering286
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
GIEQ Summary
GIEQ is the Goldman Sachs Data Enhanced International Equity ETF, an actively managed fund that invests in stocks from countries outside the U.S., such as Japan, the UK, and Europe. It uses data and research to pick a wide mix of companies across many sectors, including financials, industrials, and health care. Well-known holdings include ASML and Nestlé. Someone might invest in GIEQ to diversify beyond U.S. stocks and seek long-term global growth in a single, easy-to-trade fund. A key risk is that international stock prices can rise or fall significantly with global markets and currency swings.
How much will it cost me?This ETF has an expense ratio of 0.30%, which means you’ll pay about $3.00 per year for every $1,000 invested. That cost is a bit higher than many low-cost index ETFs because this fund is actively managed using Goldman Sachs’ data-driven and research-based approach.
What would affect this ETF?This ETF could benefit if global growth outside the U.S. stays healthy, especially for large international technology, health care, and industrial companies like ASML, AstraZeneca, and Siemens, and if stable or falling interest rates support financial firms such as Allianz, UBS, and Mitsubishi UFJ. On the negative side, it may be hurt by slowdowns in Europe or Asia, rising global interest rates that pressure banks and borrowers, stronger U.S. dollar moves that reduce foreign stock returns for U.S. investors, or new regulations and political tensions affecting major markets and sectors like financials, materials, and energy.
GIEQ Top 10 Holdings
GIEQ leans heavily on a mix of European and global blue chips, with ASML acting as a powerful long‑term engine despite some recent stumbles, reflecting the fund’s tilt toward high‑end industrial and tech names. Financials like Allianz, HSBC, and UBS are generally rising and help anchor performance, though UBS has been more mixed. Industrial players such as Siemens and Safran add steady, if occasionally choppy, support. On the defensive side, consumer staples giants Nestlé and Unilever have been lagging, slightly dulling the fund’s overall shine. The portfolio is broadly diversified across non‑U.S. markets, with notable exposure to Europe and Australia via BHP.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 3.61% | $1.55M | €611.79B | 91.13% | 76 Outperform | |
| Roche Holding AG | 2.01% | $864.21K | $344.30B | 21.61% | 73 Outperform | |
| Nestlé SA | 1.54% | $661.39K | CHF195.59B | -0.68% | 71 Outperform | |
| Siemens | 1.51% | $648.59K | €207.41B | 8.00% | 74 Outperform | |
| BHP Group Ltd | 1.42% | $610.76K | AU$309.79B | 61.84% | 68 Neutral | |
| UBS Group AG | 1.20% | $516.23K | $145.64B | 21.11% | 73 Outperform | |
| Allianz | 1.20% | $514.03K | €157.92B | 12.80% | 67 Neutral | |
| Mitsubishi UFJ Financial Group | 1.17% | $504.87K | ¥38.71T | 52.68% | 76 Outperform | |
| Unilever | 1.16% | $500.35K | £100.68B | -7.38% | 72 Outperform | |
| SAFRAN SA | 1.10% | $470.84K | €131.83B | 6.36% | 67 Neutral |
GIEQ Technical Analysis
Negative
―
Price Trends
42.42
Negative
Market Momentum
-0.32
Positive
41.42
Neutral
25.01
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For GIEQ, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 41.72, equal to the 50-day MA of 42.42, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of -0.32 indicates Positive momentum. The RSI at 41.42 is Neutral, neither overbought nor oversold. The STOCH value of 25.01 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GIEQ.
GIEQ Peer Comparison
Comparison Results
Performance Comparison
GIEQ
Goldman Sachs Data Enhanced International Equity ETF
41.26
0.53
1.30%
PJIO
PGIM Jennison International Opportunities ETF
―
―
―
AADR
AdvisorShares Dorsey Wright ADR ETF
―
―
―
ESIM
Eventide International ETF
―
―
―
ABLG
Abacus Fcf International Leaders Etf
―
―
―
VNIE
Vontobel International Equity Active ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents